Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics

Peer Review reports

Original Submission
27 Jun 2013	Submitted	Original manuscript
18 Aug 2013	Reviewed	Reviewer Report - Mohamed Kharfan-Dabaja
16 Oct 2013	Reviewed	Reviewer Report - Hani Tamim
15 Nov 2013	Reviewed	Reviewer Report - Gert Ossenkoppele
15 Jan 2014	Author responded	Author comments - Ji¿í Mayer
Resubmission - Version 2
15 Jan 2014	Submitted	Manuscript version 2
Publishing
24 Jan 2014	Editorially accepted
6 Feb 2014	Article published	10.1186/1471-2407-14-69

Back to article page